'''Nebracetam''' is an [[investigational drug]] of the [[racetam]] family that is a [[muscarinic acetylcholine receptor|M<sub>1</sub> acetylcholine receptor]] [[agonist]] in rats.<ref>{{Cite journal | last1 = Takeo | first1 = S. | last2 = Hayashi | first2 = H. | last3 = Miyake | first3 = K. | last4 = Takagi | first4 = K. | last5 = Tadokoro | first5 = M. | last6 = Takagi | first6 = N. | last7 = Oshikawa | first7 = S. | doi = 10.1038/sj.bjp.0701161 | title = Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats | journal = British Journal of Pharmacology | volume = 121 | issue = 3 | pages = 477â€“484 | year = 1997 | pmid =  9179389| pmc =1564714 }}</ref>  Its effects in humans have not been studied.
